177 related articles for article (PubMed ID: 7006629)
1. Effect of the cryopreservation on the production of leukocyte migration inhibition factor (LIF) by lymphocytes from normal volunteers and patients with laryngeal carcinomas.
Cavallo GP; Beatrice F; Poggio E; Bussi M; Di Fortunato V; Rendine S; Sartoris A; Cortesina G
Boll Ist Sieroter Milan; 1980 May; 59(2):147-54. PubMed ID: 7006629
[TBL] [Abstract][Full Text] [Related]
2. Specific lymphokine responses in cervical nodes of patients with laryngeal cancer.
Cortesina G; Beatrice F; Morra B; Barioglio MG; Poggio E; Bussi M; DiFortunato V; Sacchi M; Rendine S; Sartoris A
Laryngoscope; 1987 Jul; 97(7 Pt 1):843-7. PubMed ID: 3298902
[TBL] [Abstract][Full Text] [Related]
3. "In vitro" and "in vivo" leukocyte migration inhibitory factor production in acute infectious mononucleosis patients.
Bertotto A; Gentili F; Stagni G; Zucchetti Z; Vaccaro R
Boll Ist Sieroter Milan; 1983 Jul; 62(3):281-6. PubMed ID: 6357231
[TBL] [Abstract][Full Text] [Related]
4. Effect of histamine on leukocyte migration tests in vertebrates. II. Study of the lack of species specificity of leukocyte inhibiting factor--production inhibitor (LIF-PI).
Rigal D; Monier JC; Mohanna K
Thymus; 1983; 5(1):53-7. PubMed ID: 6342215
[TBL] [Abstract][Full Text] [Related]
5. Use of cryopreserved lymphocytes for the indirect leukocyte migration inhibition assay.
Szigeti R; Stevens D; Ernberg I; Klein G; Masucci MG; Svedmyr E; Klein E
J Immunol Methods; 1981; 46(3):369-74. PubMed ID: 6273472
[TBL] [Abstract][Full Text] [Related]
6. [Production of the leukocyte inhibitory factor (LIF) by peripheral blood lymphocytes in vitro and LIF-like plasma activity in paraproteinemic patients].
Puppo F; Corsini G; Mangini P; Armani U; Piana A
Haematologica; 1984; 69(4):394-402. PubMed ID: 6437916
[No Abstract] [Full Text] [Related]
7. Production of leukocyte migration inhibition factor by lymphocytes of larynx cancer patients stimulated by laryngeal carcinoma solubilized membrane antigens.
Cortesina G; Cavallo GP; Beatrice F; Sartoris A; Bussi M; Morra B; Di Fortunato V; Poggio E; Rendine S
Tumori; 1982 Feb; 68(1):39-46. PubMed ID: 7041379
[TBL] [Abstract][Full Text] [Related]
8. In vitro production of leucocyte migration inhibitory factor by lymphocytes in exudative pleural effusions.
Pettersson T; Welin MG; Weber TH
J Clin Lab Immunol; 1982 Jun; 8(2):107-11. PubMed ID: 7050387
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of blocking mechanisms against immunological responses in patients with laryngeal carcinoma.
Morra B; Beatrice F; Cavallo GP; Bussi M; Di Fortunato V; Poggio E; Vercellino M; Vercellino M; Cortesina G
Laryngoscope; 1984 Jun; 94(6):825-8. PubMed ID: 6233466
[TBL] [Abstract][Full Text] [Related]
10. Deficient lymphokine production of newborn lymphocytes.
Winter HS; Gard SE; Fischer TJ; Bryson YJ; Stiehm ER
Pediatr Res; 1983 Jul; 17(7):573-8. PubMed ID: 6225985
[TBL] [Abstract][Full Text] [Related]
11. Participation of a histamine-Sepharose-adherent subpopulation of human mononuclear cells in the production of leucocyte migration inhibition factor (LIF) in healthy children.
Reichman BL; Handzel ZT; Segal S; Weinstein Y; Levin S
Clin Exp Immunol; 1979 Sep; 37(3):562-6. PubMed ID: 389498
[TBL] [Abstract][Full Text] [Related]
12. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates.
Gottlieb AA; Farmer JL; Matzura CT; Hester RB; Rosenberg JS
J Immunol; 1984 Jan; 132(1):256-60. PubMed ID: 6361122
[TBL] [Abstract][Full Text] [Related]
13. Human lymphocytes produce both leukocyte migration inhibition (LIF) and stimulation (MStF) factors after mitogen, alloantigens or antigen activation.
Favila-Castillo L; Méndez-Samperio P; Cortés-Castillo MA; Sánchez-Ortega A
Rev Latinoam Microbiol; 1988; 30(2):111-5. PubMed ID: 3064229
[No Abstract] [Full Text] [Related]
14. Leucocyte migration inhibition assay from clotted plasma droplets.
Welin MG; Mäkinen T; Weber TH
J Clin Lab Immunol; 1982 May; 8(1):65-8. PubMed ID: 6808136
[TBL] [Abstract][Full Text] [Related]
15. Specific LIF production in laryngeal cancer patients: evidence of suppressor activity exerted by adherent cells.
Cortesina G; Bussi M; Morra B; Beatrice F; Cavallo GP; Di Fortunato V; Poggio E; Rendine S; Sartoris A; Landolfo S
Tumori; 1983 Dec; 69(6):497-502. PubMed ID: 6229919
[TBL] [Abstract][Full Text] [Related]
16. [The functional characteristics of the interaction of lymphokine-producing lymphocytes with granulocytes of the peripheral blood and skin in dermatosis patients].
Kozin VM; Adamenko GP; Bogdanovich LI; Iakirevich EV
Vestn Dermatol Venerol; 1990; (3):29-32. PubMed ID: 2195796
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of interferon on the production on virus- and mitogen-induced leukocyte inhibitory factors in human leukocyte cultures.
Dinh PN; Rosztóczy I; Béládi I; Tóth M
Acta Virol; 1980 Dec; 24(6):427-32. PubMed ID: 6163345
[TBL] [Abstract][Full Text] [Related]
18. Production and characterization of supernatants with high titers of human leukocyte inhibitory factor (LIF).
McCoy JL; Braatz JA; Ames RS; Herberman RB
J Immunol; 1980 Jun; 124(6):2786-93. PubMed ID: 6989906
[No Abstract] [Full Text] [Related]
19. Monocyte regulation of lymphokine production in cancer patients.
Kowalczyk D; Ruggiero I; Zembala M
J Clin Lab Immunol; 1986 Jan; 19(1):37-41. PubMed ID: 3517344
[TBL] [Abstract][Full Text] [Related]
20. Lactoferrin stimulates the production of leucocyte migration inhibitory factor by human peripheral mononuclear leucocytes.
Kijlstra A; Broersma L
Clin Exp Immunol; 1984 Feb; 55(2):459-64. PubMed ID: 6365377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
